Invesco Ltd. Increases Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Invesco Ltd. boosted its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 14.1% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 718,016 shares of the company’s stock after acquiring an additional 88,640 shares during the period. Invesco Ltd.’s holdings in Ryan Specialty were worth $46,068,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of RYAN. Rakuten Securities Inc. acquired a new position in Ryan Specialty in the fourth quarter valued at $27,000. Principal Securities Inc. grew its holdings in Ryan Specialty by 164.7% in the 4th quarter. Principal Securities Inc. now owns 667 shares of the company’s stock valued at $43,000 after buying an additional 415 shares during the period. Mizuho Bank Ltd. acquired a new position in shares of Ryan Specialty during the 4th quarter valued at about $49,000. Headlands Technologies LLC lifted its holdings in shares of Ryan Specialty by 2,644.8% during the 4th quarter. Headlands Technologies LLC now owns 796 shares of the company’s stock worth $51,000 after acquiring an additional 767 shares during the period. Finally, Harvest Fund Management Co. Ltd acquired a new stake in shares of Ryan Specialty in the fourth quarter worth approximately $54,000. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Ryan Specialty

In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of the stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Nicholas Dominic Cortezi sold 10,485 shares of the stock in a transaction dated Thursday, January 23rd. The stock was sold at an average price of $65.12, for a total transaction of $682,783.20. Following the sale, the director now owns 11,109 shares in the company, valued at approximately $723,418.08. This trade represents a 48.56 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 176,894 shares of company stock valued at $11,779,720 in the last three months. Corporate insiders own 11.10% of the company’s stock.

Ryan Specialty Trading Down 1.5 %

NYSE RYAN opened at $73.08 on Wednesday. The stock has a market cap of $19.14 billion, a P/E ratio of 105.91, a PEG ratio of 1.19 and a beta of 0.66. The company’s fifty day simple moving average is $70.25 and its 200-day simple moving average is $68.97. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a 52 week low of $48.48 and a 52 week high of $77.16.

Ryan Specialty (NYSE:RYAN) last issued its quarterly earnings data on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02). The firm had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. Equities research analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were issued a dividend of $0.12 per share. The ex-dividend date of this dividend was Tuesday, March 4th. This is an increase from Ryan Specialty’s previous quarterly dividend of $0.11. This represents a $0.48 annualized dividend and a yield of 0.66%. Ryan Specialty’s payout ratio is currently 69.57%.

Wall Street Analysts Forecast Growth

RYAN has been the subject of several research analyst reports. Barclays dropped their price target on shares of Ryan Specialty from $88.00 to $83.00 and set an “overweight” rating for the company in a research report on Friday, April 11th. Keefe, Bruyette & Woods cut their target price on Ryan Specialty from $76.00 to $75.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 9th. UBS Group boosted their price target on Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a research report on Wednesday, February 26th. TD Cowen began coverage on Ryan Specialty in a report on Thursday, April 10th. They issued a “buy” rating and a $89.00 price objective on the stock. Finally, Royal Bank of Canada decreased their target price on Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a report on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $75.67.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.